Committee for Orphan Medicinal Products (COMP): 10-11 December 2013
Date:
10/12/2013 to 12/12/2013
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting 10-12 December 2013 (PDF/285.09 KB)
Adopted
First published: 12/03/2014
Last updated: 12/03/2014
EMA/COMP/687306/2013 -
List item
COMP meeting report on the review of applications for orphan designation: December 2013 (PDF/132.98 KB)
First published: 13/01/2014
Last updated: 13/01/2014
EMA/COMP/699713/2013 -
List item
Agenda - COMP agenda of the 10-12 December 2013 meeting (PDF/233.58 KB)
First published: 29/11/2013
Last updated: 29/11/2013
EMA/COMP/738467/2013